Dan Peer

Dan Peer is a Professor and Director of the Laboratory of Precision Nanomedicine and Vice President for Research at Tel Aviv University. Dan did pioneer work in developing strategies to deliver RNA payloads in a cell specific manner. He developed one of the largest lipid libraries with more than 100,000 different lipids. His lab was the first to show systemic cell specific delivery of siRNAs to immune cells. The first systemic cell specific mRNA delivery in an animal and the first to show highly efficient therapeutic genome editing in cancer in a cell type specific manner. He also developed the first extra cellular bacterial mRNA vaccine; He is the recipient of more than 40 awards and honors. He holds 148 pending and granted patents 63% of them are licensed to companies and more than 10 strategies he developed are currently in clinical testing. He is the founder of 4 startup companies (one was acquired in 2021). He has published more than 180 manuscripts; several books and gave numerous invited, plenary and keynote talks worldwide. Dan also serves as an editor and on the editorial board of more than 20 journals. Dan is an International Member of the US National Academy of Engineering and was elected in 2024 as a Fellow of the US National Academy of Inventors.